tirzepatide and anesthesia general Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia Clinical Consequences of Delayed Gastric

Neal, F

This rapid growth is driven by GLP-1s proven ability to lower blood sugar and support meaningful weight loss, making GLP-1s a game-changer for both patients and providers

It is noteworthy that the majority of these gastrointestinal manifestations are of a mild nature and predominantly occur during the titration phase (108)

Wang T, Sha L, Li Y, et al

These early signs indicate the medication is engaging your appetite-control system, though weight loss on the scale may not yet be visible

I have a long way to go before anybody would refer to me as completely healthy, and I wouldnt call myself an expert on semaglutide